Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-19-022834
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-05 16:32:51
Reporting Period:
2019-08-21
Accepted Time:
2019-09-05 16:32:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750019 Tcr2 Therapeutics Inc. TCRR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575745 Morana Jovan-Embiricos C/o Lj Partnership, 8, Rue Saint-Leger
Geneva V8 CH-1205
No No Yes No
1767418 F2 Capital I 2019, Llc C/o Singer Mckeon Inc, 8 West 38Th St
Suite 1001
New York NY 10018
No No Yes No
1768161 Ltd Ii Holdings Globeways 3Rd Floor, Geneve Place, Waterfront Dr
Po Box 3175, Road Town Tortola, Bvi
Geneva V8 CH-1205
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-21 500 $17.00 166,167 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-22 100 $17.03 166,067 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-23 3 $17.00 166,064 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-26 29,128 $17.01 136,936 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-27 1,200 $17.01 135,736 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-28 6,700 $17.01 129,036 No 4 S Indirect By Fund
Common Stock Disposition 2019-08-29 3,700 $17.01 125,336 No 4 S Indirect By Fund
Common Stock Disposition 2019-09-03 10,559 $17.01 114,777 No 4 S Indirect By Fund
Common Stock Disposition 2019-09-04 12,214 $17.55 102,563 No 4 S Indirect By Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,614,515 Indirect By Fund
Common Stock 193,742 Indirect By Fund
Common Stock 410,168 Indirect By Fund
Common Stock 449,207 Indirect By Fund
Common Stock 536,962 Indirect By Fund
Common Stock 200,000 Indirect By Fund
Footnotes
  1. The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  2. The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  3. The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  4. The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  5. The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  6. The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  7. The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited. LJ Skye Trustees Ltd. has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.